These Were The Five Best And Worst Performing Small-Cap Stocks In April 2022

0
These Were The Five Best And Worst Performing Small-Cap Stocks In April 2022
geralt / Pixabay

Small-cap stocks are companies with market capitalizations of less than $2 billion. These stocks can be very volatile, and thus, could offer impressive returns in the short-term as well. Additionally, what makes these stocks even more tempting is the Goldman Sachs data that small-cap stocks have outperformed the large-cap stocks over the past two decades, and the trend is expected to continue this year as well. Let’s take a look at the five best and worst performing small-cap stocks in April 2022.

Play Quizzes 4

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q1 2022 hedge fund letters, conferences and more

Exodus Point Outperforms As Rates Trading Profits Jump [Exclusive]

Value Bin Default RatesMichael Gelband’s Exodus Point launched in 2018 with $8.5 billion in assets. Expectations were high that the former Millennium Management executive would be able to take the skills he had learned at Izzy Englander’s hedge fund and replicate its performance, after a decade of running its fixed income business. The fund looks to be proving Read More

Five Best Performing Small-Cap Stocks In April 2022

We have used the April return data from finviz.com to come up with the five best and worst performing small-cap stocks in April 2022. First, let’s look at the five best performing small-cap stocks in April 2022:

  1. BlackBoxStocks (116%)

Founded in 2011 and headquartered in Dallas, this company makes available real-time proprietary analytics and news to stock and options traders. BlackBoxStocks Inc (NASDAQ:BLBX) shares are down over 51% YTD and over 10% in the last year. Its shares are presently trading at over $1.80, while it has a 52-week range of $1.49 and $8.00. As of writing, BlackBoxStocks’ market cap was more than $22 million.

  1. Redbox Entertainment (127%)

Founded in 2002 and headquartered in Oakbrook Terrace, Ill., this company produces, acquires and distributes movies through its Redbox Entertainment Inc (NASDAQ:RDBX) brand. Redbox Entertainment shares are down almost 64% YTD and almost 73% in the last year. Its shares are presently trading at over $2.40, while it has a 52-week range of $1.6101 and $27.22. As of writing, Redbox Entertainment’s market cap was more than $145 million.

  1. Veru (136%)

Founded in 1996 and headquartered in Miami, this company develops medicines for the management of prostate cancer and breast cancer. Veru Inc (NASDAQ:VERU) shares are up over 53% YTD and over 19% in the last year. Its shares are presently trading at over $9.60, while it has a 52-week range of $4.34 and $17.50. As of writing, Veru’s market cap was more than $650 million.

  1. Checkmate Pharmaceuticals (222%)

Founded in 2015 and headquartered in Cambridge, Mass., this company deals in developing proprietary technology to use the immune system's power to combat cancer. Checkmate Pharmaceuticals Inc (NASDAQ:CMPI) shares are up over 260% YTD and over 50% in the last year. Its shares are presently trading at over $10.40, while it has a 52-week range of $2.00 and $10.48. As of writing, Checkmate Pharmaceuticals’ market cap was more than $220 million.

  1. Cyngn (275%)

Founded in 2013 and headquartered in Menlo Park, Calif., it is an autonomous vehicle technology company that focuses on finding industrial uses for autonomous vehicles. Cyngn Inc (NASDAQ:CYN) shares are down over 15% YTD but are up over 140% in the last three months. Its shares are presently trading at over $3.60, while it has a 52-week range of $1.08 and $9.91. As of writing, Cyngn’s market cap was more than $90 million.

Five Worst Performing Small-Cap Stocks In April 2022

Following are the five worst performing small-cap stocks in April 2022:

  1. Agile Therapeutics (-76%)

Founded in 1997 and headquartered in Princeton, N.J., this healthcare company develops and commercializes transdermal patches. Agilent Technologies Inc (NYSE:A) shares are down over 90% YTD and over 95% in the last year. Its shares are presently trading at over $1.60, while it has a 52-week range of $1.58 and $69.60. As of writing, Agile Therapeutics’ market cap was more than $6 million.

  1. Iveda Solutions (-77%)

Founded in 2003 and headquartered in Mesa, AZ, this company enables cloud video surveillance through its Sentir data and video management platform. Iveda Solutions Inc (NASDAQ:IVDA) shares are down over 90% YTD and over 80% in the last year. Its shares are presently trading at over $1.10, while it has a 52-week range of $0.9709 and $19.52. As of writing, Iveda Solutions’ market cap was more than $12 million.

  1. Genocea Biosciences (-78%)

Founded in 2006 and headquartered in Cambridge, Mass., this company develops and commercializes cancer vaccines. Genocea Biosciences Inc (NASDAQ:GNCA) shares are down over 85% YTD and over 90% in the last year. Its shares are presently trading at over $0.18, while it has a 52-week range of $0.1601 and $2.68. As of writing, Genocea Biosciences’ market cap was more than $9 million.

  1. Blue Water Vaccines (-93%)

Founded in 2018 and headquartered in Cincinnati, this biotechnology company focuses on developing transformational vaccines to prevent infectious diseases worldwide. Blue Water Vaccines Inc (NASDAQ:BWV) shares are up over 70% in the last five days. Its shares are presently trading over $6.50, while it has a 52-week range of $3.26 and $90.90. As of writing, Blue Water Vaccines’ market cap was more than $70 million.

  1. Kaleido Biosciences (-97%)

Founded in 2015 and headquartered in Lexington, Mass., this clinical stage healthcare company leverages the microbiome organ to treat disease and improve human health. Kaleido Biosciences Inc (OTCMKTS:KLDO) shares are down over 97% YTD and over 99% in the last one year. Its shares are presently trading over $0.04, while it has a 52-week range of $0.0411 and $9.470. As of writing, Kaleido Biosciences’ market cap was more than $2 million.

Updated on

No posts to display